• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆液性卵巢癌中获得性单亲二体的预后相关性

Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.

作者信息

Tuna Musaffe, Ju Zhenlin, Smid Marcel, Amos Christopher I, Mills Gordon B

机构信息

Departments of Epidemiology, Unit 1340, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA.

Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Mol Cancer. 2015 Feb 3;14(1):29. doi: 10.1186/s12943-015-0289-1.

DOI:10.1186/s12943-015-0289-1
PMID:25644622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4320828/
Abstract

BACKGROUND

Acquired uniparental disomy (aUPD) can lead to homozygosity for tumor suppressor genes or oncogenes. Our purpose is to determine the frequency and profile aUPD regions in serous ovarian cancer (SOC) and investigated the association of aUPD with clinical features and patient outcomes.

METHODS

We analyzed single nucleotide polymorphism (SNP) array-based genotyping data on 532 SOC specimens from The Cancer Genome Atlas database to identify aUPD regions. Cox univariate regression and Cox multivariate proportional hazards analyses were performed for survival analysis.

RESULTS

We found that 94.7% of SOC samples harbored aUPD; the most common aUPD regions were in chromosomes 17q (76.7%), 17p (39.7%), and 13q (38.3%). In Cox univariate regression analysis, two independent regions of aUPD on chromosome 17q (A and C), and whole-chromosome aUPD were associated with shorter overall survival (OS), and five regions on chromosome 17q (A, D-G) and BRCA1 were associated with recurrence-free survival time. In Cox multivariable proportional hazards analysis, whole-chromosome aUPD was associated with shorter OS. One region of aUPD on chromosome 22q (B) was associated with unilateral disease. A statistically significant association was found between aUPD at TP53 loci and homozygous mutation of TP53 (p < 0.0001).

CONCLUSIONS

aUPD is a common event and some recurrent loci are associated with a poor outcome for patients with serous ovarian cancer.

摘要

背景

获得性单亲二体(aUPD)可导致肿瘤抑制基因或癌基因纯合。我们的目的是确定浆液性卵巢癌(SOC)中aUPD区域的频率和特征,并研究aUPD与临床特征和患者预后的关联。

方法

我们分析了来自癌症基因组图谱数据库的532例SOC标本基于单核苷酸多态性(SNP)阵列的基因分型数据,以识别aUPD区域。进行Cox单因素回归和Cox多因素比例风险分析用于生存分析。

结果

我们发现94.7%的SOC样本存在aUPD;最常见的aUPD区域位于17号染色体长臂(76.7%)、17号染色体短臂(39.7%)和13号染色体长臂(38.3%)。在Cox单因素回归分析中,17号染色体长臂上两个独立的aUPD区域(A和C)以及全染色体aUPD与总生存期(OS)缩短相关,17号染色体长臂上的五个区域(A、D - G)和BRCA1与无复发生存时间相关。在Cox多因素比例风险分析中,全染色体aUPD与较短的OS相关。22号染色体长臂上一个aUPD区域(B)与单侧疾病相关。在TP53基因座的aUPD与TP53纯合突变之间发现有统计学意义的关联(p < 0.0001)。

结论

aUPD是一个常见事件,一些反复出现的基因座与浆液性卵巢癌患者的不良预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/7e8eba860544/12943_2015_289_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/0e18028426bb/12943_2015_289_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/ab13890a0a96/12943_2015_289_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/7e8eba860544/12943_2015_289_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/0e18028426bb/12943_2015_289_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/ab13890a0a96/12943_2015_289_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f3d/4320828/7e8eba860544/12943_2015_289_Fig3_HTML.jpg

相似文献

1
Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.浆液性卵巢癌中获得性单亲二体的预后相关性
Mol Cancer. 2015 Feb 3;14(1):29. doi: 10.1186/s12943-015-0289-1.
2
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.全基因组获得性单亲二体性分析揭示头颈部鳞状细胞癌的预后因素。
Neoplasia. 2019 Nov;21(11):1102-1109. doi: 10.1016/j.neo.2019.08.008. Epub 2019 Nov 14.
3
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer.原发性乳腺癌中获得性单亲二体性(aUPD)的预后价值。
Breast Cancer Res Treat. 2012 Feb;132(1):189-96. doi: 10.1007/s10549-011-1579-y. Epub 2011 May 21.
4
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations.全基因组分析头颈部鳞状细胞癌揭示 HPV、TP53、吸烟和酒精相关等位基因获得性单亲二体性基因组改变。
Neoplasia. 2019 Feb;21(2):197-205. doi: 10.1016/j.neo.2018.12.002. Epub 2019 Jan 4.
5
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma.肺鳞癌和肺腺癌中获得性单亲二体和纯合性缺失的常见和独特模式。
Neoplasia. 2023 Nov;45:100932. doi: 10.1016/j.neo.2023.100932. Epub 2023 Oct 4.
6
Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.乳腺癌中获得性单亲二体性和纯合突变与 HER2/ER/PR 状态的关系。
PLoS One. 2010 Nov 30;5(11):e15094. doi: 10.1371/journal.pone.0015094.
7
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.来自与患者预后相关的明确起源人群的 TP53 和 p53 注释高级别卵巢浆液性癌的基因组景观。
PLoS One. 2012;7(9):e45484. doi: 10.1371/journal.pone.0045484. Epub 2012 Sep 20.
8
Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers.胃肠道癌中体细胞获得性和组成型单亲二体性的定量分析。
Int J Cancer. 2019 Feb 1;144(3):513-524. doi: 10.1002/ijc.31936. Epub 2018 Dec 3.
9
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.新辅助化疗后腹水消退对 IIIc 至 IV 期高级别浆液性卵巢癌治疗结局的预测作用
J Ovarian Res. 2016 Dec 2;9(1):85. doi: 10.1186/s13048-016-0294-z.
10
Acquired uniparental disomy of chromosome 9p in hematologic malignancies.血液系统恶性肿瘤中9号染色体短臂的获得性单亲二体性。
Exp Hematol. 2016 Aug;44(8):644-52. doi: 10.1016/j.exphem.2015.11.005. Epub 2015 Dec 2.

引用本文的文献

1
Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.获得性单亲二体区域与口腔和口咽癌患者的疾病预后相关,但与喉癌患者无关。
Transl Oncol. 2020 May;13(5):100763. doi: 10.1016/j.tranon.2020.100763. Epub 2020 Apr 15.
2
[Research progress on uniparental disomy in cancer].[癌症单亲二体的研究进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Jul 25;48(5):560-566. doi: 10.3785/j.issn.1008-9292.2019.10.15.
3
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.

本文引用的文献

1
Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.杂合性丢失在老年卵巢癌患者中更为常见。
Genes Chromosomes Cancer. 2013 Sep;52(9):794-801. doi: 10.1002/gcc.22075. Epub 2013 May 28.
2
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome.高级别浆液性卵巢癌中基因组不稳定性的特征可预测治疗结果。
Clin Cancer Res. 2012 Oct 15;18(20):5806-15. doi: 10.1158/1078-0432.CCR-12-0857. Epub 2012 Aug 21.
3
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.
全基因组获得性单亲二体性分析揭示头颈部鳞状细胞癌的预后因素。
Neoplasia. 2019 Nov;21(11):1102-1109. doi: 10.1016/j.neo.2019.08.008. Epub 2019 Nov 14.
4
Screening of triploid with low-coverage whole-genome sequencing by a single-nucleotide polymorphism-based test in miscarriage tissue.利用基于单核苷酸多态性的检测方法,通过低覆盖度全基因组测序筛查流产组织中的三倍体。
J Assist Reprod Genet. 2019 Dec;36(12):2525-2531. doi: 10.1007/s10815-019-01588-6. Epub 2019 Nov 13.
5
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations.全基因组分析头颈部鳞状细胞癌揭示 HPV、TP53、吸烟和酒精相关等位基因获得性单亲二体性基因组改变。
Neoplasia. 2019 Feb;21(2):197-205. doi: 10.1016/j.neo.2018.12.002. Epub 2019 Jan 4.
6
Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers.胃肠道癌中体细胞获得性和组成型单亲二体性的定量分析。
Int J Cancer. 2019 Feb 1;144(3):513-524. doi: 10.1002/ijc.31936. Epub 2018 Dec 3.
7
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.Hürthle 细胞癌的综合基因组分析揭示了致癌驱动因素、反复发生的线粒体突变和独特的染色体景观。
Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.
8
Uniparental disomy and prenatal phenotype: Two case reports and review.单亲二体与产前表型:两例病例报告及文献综述
Medicine (Baltimore). 2017 Nov;96(45):e8474. doi: 10.1097/MD.0000000000008474.
9
Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.具有拷贝数改变的癌基因中突变等位基因特异性失衡:发生情况、机制及潜在临床意义。
Cancer Lett. 2017 Jan 1;384:86-93. doi: 10.1016/j.canlet.2016.10.013. Epub 2016 Oct 8.
10
SNPs Array Karyotyping in Non-Hodgkin Lymphoma.非霍奇金淋巴瘤中的单核苷酸多态性阵列核型分析
Microarrays (Basel). 2015 Nov 12;4(4):551-69. doi: 10.3390/microarrays4040551.
全基因组杂合性缺失和核苷酸分辨率下单等位基因表达的综合分析揭示了三阴性乳腺癌中失调的通路。
Genome Res. 2012 Oct;22(10):1995-2007. doi: 10.1101/gr.137570.112. Epub 2012 May 25.
4
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer.剖析“PI3K 特征”:卵巢癌个体化治疗的复杂性。
Cancer Discov. 2012 Jan;2(1):16-8. doi: 10.1158/2159-8290.CD-11-0323.
5
Integrated genomic analyses of ovarian carcinoma.卵巢癌的综合基因组分析。
Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166.
6
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.上皮性卵巢癌的分子发病机制和卵巢外起源——改变模式。
Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003.
7
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer.原发性乳腺癌中获得性单亲二体性(aUPD)的预后价值。
Breast Cancer Res Treat. 2012 Feb;132(1):189-96. doi: 10.1007/s10549-011-1579-y. Epub 2011 May 21.
8
Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.卵巢癌的组织学、分子和细胞遗传学特征:对诊断和治疗的影响。
Radiographics. 2011 May-Jun;31(3):625-46. doi: 10.1148/rg.313105066.
9
CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.CARMA3 对于 EGFR 诱导的 NF-κB 激活和肿瘤进展至关重要。
Cancer Res. 2011 Mar 15;71(6):2183-92. doi: 10.1158/0008-5472.CAN-10-3626.
10
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.